CN104274410B - 一种含达比加群酯或其盐的药物组合物 - Google Patents
一种含达比加群酯或其盐的药物组合物 Download PDFInfo
- Publication number
- CN104274410B CN104274410B CN201410316931.2A CN201410316931A CN104274410B CN 104274410 B CN104274410 B CN 104274410B CN 201410316931 A CN201410316931 A CN 201410316931A CN 104274410 B CN104274410 B CN 104274410B
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- salt
- dabigatran etcxilate
- organic acid
- content
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (31)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410316931.2A CN104274410B (zh) | 2013-07-04 | 2014-07-04 | 一种含达比加群酯或其盐的药物组合物 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310280825.9 | 2013-07-04 | ||
CN2013102808259 | 2013-07-04 | ||
CN201310280825 | 2013-07-04 | ||
CN201410316931.2A CN104274410B (zh) | 2013-07-04 | 2014-07-04 | 一种含达比加群酯或其盐的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104274410A CN104274410A (zh) | 2015-01-14 |
CN104274410B true CN104274410B (zh) | 2019-04-26 |
Family
ID=52250079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410316931.2A Active CN104274410B (zh) | 2013-07-04 | 2014-07-04 | 一种含达比加群酯或其盐的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104274410B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101980697A (zh) * | 2008-03-28 | 2011-02-23 | 贝林格尔.英格海姆国际有限公司 | 制备口服给药的达比加群制剂的方法 |
CN102793699A (zh) * | 2012-08-06 | 2012-11-28 | 严轶东 | 一种含有达比加群酯的药用组合物 |
CN103127109A (zh) * | 2013-02-05 | 2013-06-05 | 南京华威医药科技开发有限公司 | 含达比加群酯或其盐和水合物的药用组合 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011110478A1 (en) * | 2010-03-08 | 2011-09-15 | Ratiopharm Gmbh | Dabigatran etexilate-containing pharmaceutical composition |
-
2014
- 2014-07-04 CN CN201410316931.2A patent/CN104274410B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101980697A (zh) * | 2008-03-28 | 2011-02-23 | 贝林格尔.英格海姆国际有限公司 | 制备口服给药的达比加群制剂的方法 |
CN102793699A (zh) * | 2012-08-06 | 2012-11-28 | 严轶东 | 一种含有达比加群酯的药用组合物 |
CN103127109A (zh) * | 2013-02-05 | 2013-06-05 | 南京华威医药科技开发有限公司 | 含达比加群酯或其盐和水合物的药用组合 |
Also Published As
Publication number | Publication date |
---|---|
CN104274410A (zh) | 2015-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1886119B (zh) | 泮托拉唑多颗粒制剂 | |
RU2428176C2 (ru) | Системы доставки лекарственного средства, содержащие слабоосновные лекарственные средства и органические кислоты | |
CN100402021C (zh) | 包含3-(3-二甲基氨基-1-乙基-2-甲基-丙基)苯酚并能提供活性成分的延迟释放的药物 | |
AU2002330211B2 (en) | Timed, sustained release multi-particulate dosage forms of propranolol | |
JP4260370B2 (ja) | 塩酸ファスジルの経口徐放性製剤 | |
KR101774676B1 (ko) | 히드로모르폰 및 날록손을 포함하는 제약 조성물 | |
JP2005516020A (ja) | ゼロ次持続放出剤形およびその製造方法 | |
NZ201008A (en) | Oral preparations containing dipyridamole and at least 5 molar equivalents of orally acceptable acidic excipient | |
AU2002330211A1 (en) | Timed, sustained release multi-particulate dosage forms of propranolol | |
HU197839B (en) | Process for producing metoprolol containing pharmaceutical compositions | |
JP2011513498A (ja) | 弱塩基性薬物と有機酸とを含む薬物送達システム | |
JP2019527700A (ja) | タムスロシン塩酸塩含有徐放性ペレットを含む、溶出率が制御された経口投与用薬剤学的製剤 | |
US7192608B2 (en) | Method of manufacturing drug granules, the drug granules and pharmaceutical preparation containing the drug granules | |
US7163696B2 (en) | Pharmaceutical formulations | |
WO2010128525A2 (en) | A formulation of ivabradine for treating the cardiovascular disease | |
EP3813831B1 (en) | Extended release compositions comprising trihexyphenidyl | |
CN103655480B (zh) | 一种美托洛尔的缓释药物及其制备方法 | |
CN109789102A (zh) | 包含埃索美拉唑或其药学上可接受的盐的具有改善pH依赖性药物释放特性的制剂 | |
CN100475197C (zh) | 口服的可持续释放的药用组合物 | |
CN104274444B (zh) | 达比加群酯或其盐的口服双微丸药物组合物 | |
CN104274410B (zh) | 一种含达比加群酯或其盐的药物组合物 | |
US20230084129A1 (en) | Pharmaceutical composition comprising esomeprazole and sodium bicarbonate having excellent release properties | |
JP2018508501A (ja) | タムスロシン塩酸塩含有徐放性顆粒を含む経口用薬剤学的製剤 | |
CN103505421B (zh) | 一种盐酸度洛西汀的肠溶微丸制剂 | |
CN107648231B (zh) | 右兰索拉唑药物制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information |
Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL Co.,Ltd. |
|
COR | Change of bibliographic data | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB02 | Change of applicant information |
Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: Jiangsu best Pharmaceutical Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: Jiangsu best Pharmaceutical Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160324 Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |